The Neoplastic Hematopathology fellowship involves one to two years of selective, neoplastic hematopathology training. The curriculum of the fellowship and fellows’ responsibilities are designed to fit the fellow’s career goals, with training in diagnostic neoplastic hematopathology, research, and test development in neoplastic hematopathology.
The Neoplastic Hematopathology fellowship is not ACGME accredited, and completion of this fellowship alone does not grant the opportunity to sit for the American Board of Pathology Hematopathology board examination. The fellowship is designed to provide fellows with additional clinical and research experience supplemental to an ACGME accredited hematopathology fellowship, and in some cases, to provide foreign pathologists with hematopathology training that is unavailable in their home country.
The Hematopathology Service at Memorial Sloan Kettering (MSK) is a high-volume clinical service where 20000 hematological malignancy biopsies and flow cytometry cases are accessioned per year. Eighteen hematopathology faculty are enthusiastically engaged in teaching the fellows in all areas of hematopathology. Didactic lectures and microscope sessions are given by the faculty to the fellows throughout the year. The fellow is exposed to research opportunities based on a high-volume MSKCC hospital clinical service as well as an extramural consult service. In addition, participation is required in relevant educational activities, such as weekly consensus/interesting case conference, weekly lymphoma and leukemia tumor boards, journal clubs, as well as other academic activities offered by the Department of Pathology and Hematology/Oncology Departments.
Deadline for application/recruitment dates
Apply at least 12 months prior to anticipated start date
Positions available
1 per academic year
Length of program
1-2 years
Eligibility
For applicants that completed residency training in pathology in the United States:
Completion of an ACGME accredited residency (AP/CP or AP only) with eligibility or completion of the corresponding American Board of Pathology board examination.
For applicants who have not undergone residency training in pathology in the United States:
Candidates must be graduates of a recognized foreign medical school and have completed a general pathology residency program in their country of residence. The candidate must have passed the USMLE examinations (Steps 1, 2, and 3) and hold a valid ECFMG certificate. The candidate who is selected must qualify for and obtain a limited permit to practice medicine from the New York State Education Department, in accordance with its requirements. The candidate must certify intent to return to their home country upon completion of the training.
